Metabolic Syndrome in Diabetic Smokers Using Cigarettes & Combustion-Free Nicotine Delivery Systems (DIASMOKE)

Clinical Trial ID NCT04231838

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04231838

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001 118.65
2 The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991 63.91
3 Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med 2015 9.70
4 Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 2016 5.87
5 Liraglutide and Renal Outcomes in Type 2 Diabetes. N Engl J Med 2017 4.42
6 The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999 3.83
7 Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 1998 3.34
8 Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf 2014 3.23
9 Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2015 2.29
10 A fresh look at tobacco harm reduction: the case for the electronic cigarette. Harm Reduct J 2013 1.93
11 The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey. Diabetes Care 2006 1.60
12 Treatment of nicotine addiction: present therapeutic options and pipeline developments. Trends Pharmacol Sci 2011 1.55
13 Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial. J Gen Intern Med 2007 1.53
14 Effectiveness of the electronic cigarette: An eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int J Environ Res Public Health 2014 1.47
15 Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus. Arch Intern Med 2002 1.38
16 Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit. BMC Public Health 2014 1.14
17 Reliability and validity of measures taken during the Chester step test to predict aerobic power and to prescribe aerobic exercise. Br J Sports Med 2004 1.11
18 Trends in cigarette smoking among US adults with diabetes: findings from the Behavioral Risk Factor Surveillance System. Prev Med 2004 1.05
19 Smoking cessation in adults with diabetes: a systematic review and meta-analysis of data from randomised controlled trials. BMJ Open 2014 1.01
20 Prevalence of the metabolic syndrome among US middle-aged and older adults with and without diabetes--a preliminary analysis of the NHANES 1999-2002 data. Ethn Dis 2007 1.00
21 Excess risk of mortality and cardiovascular events associated with smoking among patients with diabetes: meta-analysis of observational prospective studies. Int J Cardiol 2012 1.00
22 Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. Am J Med Sci 2004 0.92
23 Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India. Glob J Health Sci 2013 0.91
24 Relation of Smoking With Total Mortality and Cardiovascular Events Among Patients With Diabetes Mellitus: A Meta-Analysis and Systematic Review. Circulation 2015 0.88
25 Diagnosing metabolic syndrome in type 2 diabetes: does it matter? QJM 2008 0.87
26 Comparison of a low-energy diet and a very low-energy diet in sedentary obese individuals: a pragmatic randomized controlled trial. Clin Obes 2011 0.87
27 The ORLIstat and CArdiovascular risk profile in patients with metabolic syndrome and type 2 DIAbetes (ORLICARDIA) Study. Curr Med Res Opin 2004 0.86
28 Relevance of endothelial-haemostatic dysfunction in cigarette smoking. Curr Med Chem 2007 0.84
29 Persisting long term benefits of smoking abstinence and reduction in asthmatic smokers who have switched to electronic cigarettes. Discov Med 2016 0.82
30 Smoking cessation: present status and future perspectives. Curr Opin Pharmacol 2012 0.82
31 Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance. Diabetes Obes Metab 2013 0.79
32 Blood Pressure Control in Smokers with Arterial Hypertension Who Switched to Electronic Cigarettes. Int J Environ Res Public Health 2016 0.79
33 Trends in tobacco use among US adults with chronic health conditions: National Survey on Drug Use and Health 2005-2013. Prev Med 2016 0.77
34 Routine Screening and Consultation Facilitate Improvement of Metabolic Syndrome. J Korean Med Sci 2015 0.75
Next 100